Quoin Pharmaceuticals Ltd ADR (QNRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2018 | 06-2018 | 03-2018 | 12-2017 | 09-2017 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 6,447 | 5,706 | 7,151 | 3,961 | 6,396 |
| Marketable Securities | N/A | 2,507 | 2,703 | 4,038 | 2,833 |
| Receivables | 164 | 254 | 217 | 236 | 284 |
| TOTAL | $6,611 | $8,467 | $10,071 | $8,235 | $9,513 |
| Non-Current Assets | |||||
| PPE Net | 458 | 376 | 399 | 388 | 360 |
| Other Non-Current Assets | 131 | 133 | 180 | 138 | 114 |
| TOTAL | $589 | $509 | $579 | $526 | $474 |
| Total Assets | $7,200 | $8,976 | $10,650 | $8,761 | $9,987 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 938 | 821 | 915 | 1,182 | 943 |
| Other current liabilities | N/A | N/A | N/A | N/A | 693 |
| TOTAL | $938 | $821 | $915 | $1,182 | $1,636 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 1,745 | 2,095 | 2,003 | 2,141 | 2,443 |
| TOTAL | $1,745 | $2,095 | $2,003 | $2,141 | $2,443 |
| Total Liabilities | $2,683 | $2,916 | $2,918 | $3,323 | $4,079 |
| Shareholders' Equity | |||||
| Retained earnings | -22,141 | -20,139 | -19,214 | -18,444 | -17,165 |
| Other shareholders' equity | 3,523 | 3,268 | 2,915 | 2,988 | 3,300 |
| TOTAL | $4,517 | $6,060 | $7,732 | $5,438 | $5,908 |
| Total Liabilities And Equity | $7,200 | $8,976 | $10,650 | $8,761 | $9,987 |